| Clinical features of 24 patients with rebound‐associated vertebral fractures after denosumab discontinuation: systematic review and additional cases AD Anastasilakis, SA Polyzos, P Makras, B Aubry‐Rozier, S Kaouri, ... Journal of Bone and Mineral Research 32 (6), 1291-1296, 2017 | 355 | 2017 |
| Effects of two years of daily teriparatide treatment on BMD in postmenopausal women with severe osteoporosis with and without prior antiresorptive treatment BM Obermayer‐Pietsch, F Marin, EV McCloskey, P Hadji, J Farrerons, ... Journal of bone and mineral research 23 (10), 1591-1600, 2008 | 316 | 2008 |
| Obesity, osteoporosis and bone metabolism K Gkastaris, DG Goulis, M Potoupnis, AD Anastasilakis, G Kapetanos Journal of musculoskeletal & neuronal interactions 20 (3), 372, 2020 | 298 | 2020 |
| Selenium supplementation in the treatment of Hashimoto's thyroiditis: a systematic review and a meta-analysis KA Toulis, AD Anastasilakis, TG Tzellos, DG Goulis, D Kouvelas Thyroid 20 (10), 1163-1173, 2010 | 298 | 2010 |
| Fracture risk and management of discontinuation of denosumab therapy: a systematic review and position statement by ECTS E Tsourdi, MC Zillikens, C Meier, JJ Body, E Gonzalez Rodriguez, ... The Journal of Clinical Endocrinology & Metabolism 106 (1), 264-281, 2021 | 286 | 2021 |
| Irisin in metabolic diseases SA Polyzos, AD Anastasilakis, ZA Efstathiadou, P Makras, N Perakakis, ... Endocrine 59, 260-274, 2018 | 285 | 2018 |
| Irisin in patients with nonalcoholic fatty liver disease SA Polyzos, J Kountouras, AD Anastasilakis, EV Geladari, CS Mantzoros Metabolism 63 (2), 207-217, 2014 | 265 | 2014 |
| Clinical complications following thyroid fine‐needle biopsy: a systematic review SA Polyzos, AD Anastasilakis Clinical endocrinology 71 (2), 157-165, 2009 | 241 | 2009 |
| Circulating irisin in healthy, young individuals: day-night rhythm, effects of food intake and exercise, and associations with gender, physical activity, diet, and body composition AD Anastasilakis, SA Polyzos, ZG Saridakis, G Kynigopoulos, ... The Journal of Clinical Endocrinology & Metabolism 99 (9), 3247-3255, 2014 | 232 | 2014 |
| Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women—the six-month effect of risedronate and teriparatide SA Polyzos, AD Anastasilakis, C Bratengeier, W Woloszczuk, ... Osteoporosis international 23, 1171-1176, 2012 | 167 | 2012 |
| Circulating irisin is associated with osteoporotic fractures in postmenopausal women with low bone mass but is not affected by either teriparatide or denosumab treatment for 3 … AD Anastasilakis, SA Polyzos, P Makras, A Gkiomisi, I Bisbinas, ... Osteoporosis International 25, 1633-1642, 2014 | 155 | 2014 |
| Denosumab discontinuation and the rebound phenomenon: a narrative review AD Anastasilakis, P Makras, MP Yavropoulou, G Tabacco, AM Naciu, ... Journal of clinical medicine 10 (1), 152, 2021 | 148 | 2021 |
| Zoledronate for the prevention of bone loss in women discontinuing denosumab treatment. A prospective 2‐year clinical trial AD Anastasilakis, SE Papapoulos, SA Polyzos, NM Appelman‐Dijkstra, ... Journal of Bone and Mineral Research 34 (12), 2220-2228, 2019 | 146 | 2019 |
| Therapy of endocrine disease: denosumab vs bisphosphonates for the treatment of postmenopausal osteoporosis AD Anastasilakis, SA Polyzos, P Makras European journal of endocrinology 179 (1), R31-R45, 2018 | 131 | 2018 |
| Efficacy and safety of denosumab in postmenopausal women with osteopenia or osteoporosis: a systematic review and a meta-analysis AD Anastasilakis, KA Toulis, DG Goulis, SA Polyzos, S Delaroudis, ... Hormone and metabolic research 41 (10), 721-729, 2009 | 120 | 2009 |
| Non-invasive diagnosis of non-alcoholic steatohepatitis and fibrosis with the use of omics and supervised learning: a proof of concept study N Perakakis, SA Polyzos, A Yazdani, A Sala-Vila, J Kountouras, ... Metabolism 101, 154005, 2019 | 119 | 2019 |
| Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumab AD Anastasilakis, KA Toulis, SA Polyzos, CD Anastasilakis, P Makras Therapeutics and Clinical Risk Management, 295-306, 2012 | 112 | 2012 |
| Expression of microRNAs that regulate bone turnover in the serum of postmenopausal women with low bone mass and vertebral fractures MP Yavropoulou, AD Anastasilakis, P Makras, DG Tsalikakis, ... European Journal of Endocrinology 176 (2), 169-176, 2017 | 105 | 2017 |
| Novel therapies for osteoporosis P Makras, S Delaroudis, AD Anastasilakis Metabolism 64 (10), 1199-1214, 2015 | 102 | 2015 |
| Multiple clinical vertebral fractures following denosumab discontinuation AD Anastasilakis, P Makras Osteoporosis International 27, 1929-1930, 2016 | 98 | 2016 |
Stergios PolyzosAssociate Proffessor, Aristotle University of ThessalonikiVerifisert e-postadresse på auth.gr